Le Lézard
Classified in: Covid-19 virus
Subject: Nonprofit

AHF: Countries Can't ?Opt Out' of Global Public Health


As countries continue to negotiate a new Pandemic Accord, AHF cautions that if the new global public health instrument becomes an opt-in-only treaty, it will be less effective in protecting the world from outbreaks like COVID-19.

"You cannot opt out of global public health because it is a global good ? we all benefit from it. If some countries decide not to opt in, the treaty will be weak, and the world will remain in danger of new, deadly pandemics," said AHF President Michael Weinstein. "Instead, the treaty should be applicable to all countries, and those who do not wish to participate must openly state so. This would create a powerful incentive of ?peer pressure' for countries to remain in the treaty."

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.


These press releases may also interest you

at 07:20
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will assess monovalent vaccine candidate, encoding an...

at 07:20
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

at 07:05
Healthcare Services Group, Inc. today reported results for the three months ended March 31, 2024. Ted Wahl, Chief Executive Officer, stated, "Our team delivered strong first quarter results, building on our positive momentum in 2023. During the...

at 07:05
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development...

at 07:05
Silicon Labs , a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the first quarter, which ended March 30, 2024....

at 07:00
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a memorandum of understanding with Squamish Search and Rescue (SSAR), pursuant to which Draganfly will...



News published on and distributed by: